Please login to the form below

Not currently logged in
Email:
Password:

severe hypertriglyceridemia

This page shows the latest severe hypertriglyceridemia news and features for those working in and with pharma, biotech and healthcare.

AZ target Omthera files blood fat drug in US

AZ target Omthera files blood fat drug in US. FDA submission for Epanova in severe hypertriglyceridemia. ... The company, which is the subject of a $443m takeover by AstraZeneca (AZ), filed the drug with the Food and Drug Administration (FDA) for use in

Latest news

  • AstraZeneca offers $443m to buy Omthera AstraZeneca offers $443m to buy Omthera

    In trials, the product has been shown to reduce triglyceride levels and improve other blood lipid profiles and is due to be filed for approval for severe hypertriglyceridemia in the coming

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics